Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.
Mandelli
F
F
Department of Human Biopathology, University La Sapienza, Rome, Italy.
Tribalto
M
M
Avvisati
G
G
Cantonetti
M
M
Petrucci
M T
MT
Boccadoro
M
M
Pileri
A
A
Marmont
F
F
Resegotti
L
L
Lauta
V
V
D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control; D011897:Random Allocation; D011994:Recombinant Proteins / Q000627:therapeutic use*
D007370:Interferon Type I; D011994:Recombinant Proteins